THERAPEUTIC DEVELOPMENT OF A MONOCLONAL ANTIBODY TO TREAT CARDIOMYOPATHIES

$4,578,754FY2020Defense Health AgencyDOD

University Of California, Los Angeles

Investigators

View source on USAspending →